Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score54
United States Fiscal year ends December CIK 0001658247 Results filed 3 Aug 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
4,995
$20.02
$100.00K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
6,542
$15.29
$100.03K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
4,422
$22.61
$99.98K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
3,969
$25.19
$99.98K
Stephen F. Betz
26 Dec 2025
Chief Scientific Officer
Exercised, kept
18,000
$1.91
$34.38K
Richard Scott Struthers
18 Dec 2025
President & CEO
Exercised, kept
28,400
$15.29
$434.24K
Richard Scott Struthers
18 Dec 2025
President & CEO
Exercised, kept
16,342
$9.28
$151.65K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 3
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 4,245,150
History held since 20 Jul 2018